Second Sight Medical (EYES) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Second Sight Reports Fourth Quarter and Year End 2015 Financial Results
March 3, 2016 4:00 PM ESTSYLMAR, Calif.--(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-month and twelve-month periods ended December 31, 2015.
Recent Company Highlights:
Net revenue increased by 55% to $2.4 million in the fourth quarter of 2015; net revenue for the full year 2015 grew 163% to $8.9 million; Implanted 21 Argus® II Retinal Prosthesis Systems worldwide during the fourth quarter... More